Epigenetic Drugs: Team Players in Combo Therapies
Scientists May Be Better Able to Destroy Tumors and Possibly Reverse CNS Decline
The Challenge of Immunotherapy: Staying on Target
Immunotherapies Can Produce Side Effects That Mimic Autoimmune Diseases
Key Trends in 2018 in the Biopharmaceutical Market
Interview with Nigel Darby, Advisor, GE Healthcare Life Sciences
Top 10 Best-Selling Cancer Drugs, Q1–Q3 2017
15% Year-Over-Year Growth, with Sales Set to More than Double by 2022
For full access to this article login to GEN Select now.
Mass Spec Protein Analysis Strategies
Generating Clean and Unambiguous Data for Proteomics to Live Up to Its Promise
- Proteomics arrived on the biotech scene a decade ago, promising a new discovery route to disease markers. Much more complex than genomics, it represents the industrial-scale analysis of the vast array of proteins in their myriad configurations. It was assumed that because of their direct relationship to the organism’s ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.